CNA Financial Corporation research snapshot
CNA AI stock analysis reads CNA Financial Corporation as a long-standing U.S. commercial property and casualty insurer that earned a record $1.342 billion of core income in 2025 but posted a softer Q1 2026 after reserve strengthening on excess casualty and professional E&O lines. At the August 3, 2026 data cutoff, CNA traded near $52.47 with an independently verified market capitalization of about $14.19 billion. The stock sat above its 50-day and 200-day averages, close to the top of a $41.53 to $55.71 52-week range, while Loews Corporation still owned roughly 92% of the shares, leaving a thin public float. Q2 2026 results were scheduled to be released before the market opened on August 3, 2026. This page uses scenarios, technical levels, and source-backed facts. It is informational research, not investment advice.
Current price
$52.47
Market cap
$14.19 billion
AI score
63 / 100
Rating
Durable commercial P&C franchise, price near highs after a weak Q1
Trend status
Above 50-day and 200-day averages, near the top of its range
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | CNA earns mainly by underwriting Specialty, Commercial, and International P&C risks, then investing the float while managing run-off Life & Group and legacy Corporate liabilities. | Medium-high |
| Moat | The moat comes from broker relationships, product expertise, brand history, claims and underwriting data, and balance-sheet strength, including an AM Best financial strength rating upgraded to A+ in December 2025. Pricing power remains cyclical. | Medium |
| Management | Douglas M. Worman leads as Chairman and CEO, with Scott R. Lindquist as CFO. Capital return has been shareholder-friendly through regular dividends and a 2025 special dividend, while Loews remains the controlling owner. | Medium |
| Financial trend | FY2025 produced record core income of $1.342 billion and net income of $1.278 billion, but Q1 2026 core income fell to $225 million as the P&C combined ratio rose to 102.2% on prior-year development and catastrophes. | High |
| Valuation | At $52.47, CNA traded near 11.74x trailing EPS of $4.47, about 11.48x forward estimates, 1.31x Q1 2026 book value of $40.13, and roughly 3.66% on the $0.48 quarterly regular dividend, before counting the 2026 special dividend. | High |
| Technical trend | As of the late-July 2026 snapshot, CNA traded above its 50-day ($47.97) and 200-day ($46.95) moving averages near the top of the 52-week range, with beta near 0.30 and RSI near 55.8. | Medium-high |
| Risk level | Key risks are casualty social inflation, adverse prior-year development, catastrophes, investment marks, run-off long-term care and mass tort, and thin free float under Loews control. | Medium-high |
| AI confidence | High for descriptive filings and verified calculations. Lower for exact stock outcomes because insurance results can change quickly after reserve updates or catastrophe quarters. | High data confidence |
| Investment certainty | Medium certainty. The commercial franchise is durable, but a buy decision depends on price near the highs, Q2 2026 results, reserve confidence after Q1 actions, dividend sustainability, and tolerance for controlling-shareholder structure. | Medium |
CNA AI stock forecast
The CNA AI stock forecast uses scenario math around the $52.47 quote and roughly $4.57 of consensus forward earnings. The three-year framework produced a bearish area near $32 to $38, a base area near $50 to $56, and a bullish area near $66 to $72 before dividends, with Q2 2026 results due on the cutoff date acting as the near-term trigger.
$66 to $72
More likely if core EPS compounds near 7% annually, underlying combined ratios move back toward the low 90s, reserve development stabilizes, Q2 2026 results reassure, and investors re-rate the stock toward about 12 to 13x earnings.
$50 to $56
More likely if EPS grows near 3% annually, underwriting normalizes after the Q1 2026 reserve action, the regular dividend is maintained, and the market values CNA near 11x earnings close to the current price band.
$32 to $38
More likely if social inflation, further adverse development, catastrophe losses, or weaker investment income cut EPS and the multiple compresses toward about 8 to 9x, a zone consistent with the cautious sell-side target of $45 and below.
CNA AI technical analysis
CNA AI technical analysis is constructive but extended as of the August 3, 2026 cutoff. StockAnalysis data from the July 31, 2026 close showed a 50-day moving average near $47.97 and a 200-day moving average near $46.95, with price trading above both after a rally toward the $55.71 52-week high. Q2 2026 results, scheduled for August 3, 2026, were the immediate catalyst.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $52.47 | StockAnalysis close on July 31, 2026, used for market cap and valuation math at the August 3, 2026 cutoff. |
| Near support | $46.95 to $47.97 | The 200-day and 50-day moving average band from late-July StockAnalysis data is the first intermediate support zone after a pullback from recent highs. |
| Near resistance | $53.30 to $55.71 | The July 31, 2026 day high near $53.30 and the 52-week high of $55.71 are the nearest upside ceilings for the stock. |
| 50-day moving average | $47.97 | Price was well above this level in late July, supporting the intermediate rebound unless the average is reclaimed lower. |
| 200-day moving average | $46.95 | Price was above the 200-day average, keeping the longer-term trend constructive unless this level breaks with volume. |
| Momentum | RSI near 55.8 after a 52-week gain near 19% | Positive but not overbought. The stock recovered from the low-$40s area toward $52+, so proximity to highs raises failed-breakout risk around the Q2 report. |
| Volume | About 0.49 million average daily shares | StockAnalysis listed average volume near 489,000 shares over 20 days. Thin free float under Loews ownership can amplify price moves. |
| Volatility | Beta 0.30 | Low beta understates event risk around reserve, catastrophe, and earnings surprises, including the August 3, 2026 Q2 release. |
| Invalidation | Close below $46.95, then $47.97 | A close below the 200-day average would weaken the rebound thesis. A break below the 50-day average would be a deeper short-term warning. |
CNA AI trading strategy
The CNA AI trading strategy is a rules-based research framework for a majority-owned commercial P&C insurer with strong 2025 results, Q1 2026 reserve pressure, a meaningful dividend, and a Q2 2026 report due at the data cutoff. It is not personal advice and should be paired with live quotes, filings, position sizing, and risk controls.
Watch for CNA to hold above the $46.95 to $47.97 moving-average band and clear the $53.30 to $55.71 resistance zone with better than average volume after the Q2 report.
A close below $46.95 or a failed breakout after earnings or catastrophe news should invalidate the short-term setup.
If CNA pulls back toward the 200-day average without a new reserve, catastrophe, or dividend shock, compare the reaction with book value, combined ratio, and core ROE.
Do not average down without a defined loss limit because casualty reserve news can reprice the stock quickly and free float is limited.
Track P&C net written premiums, combined ratio, underlying combined ratio, prior-year development, catastrophe points, net investment income, book value ex AOCI, regular dividend coverage, and Life & Group plus Corporate run-off losses.
Reduce confidence if core income relies mainly on investment income while underwriting stays unprofitable, if reserve strengthening continues for multiple quarters, or if Q2 2026 results disappoint at a price near the 52-week high.
Investment research summary
Customers pay CNA to transfer commercial property, casualty, specialty, and professional liability risks. The company earns from underwriting discipline, broker distribution, claims handling, and investment income on insurance float, while run-off Life & Group and legacy liabilities remain non-core overhangs.
The moat is strongest in broker relationships, specialty product knowledge, multi-decade brand presence, underwriting data, and capital strength, underlined by the AM Best upgrade to A+ in late 2025. It narrows when competitors cut price, social inflation outruns rate, or reserve shortfalls force catch-up charges.
The thesis fails if excess casualty and professional liability reserves keep deteriorating, catastrophes cluster, investment income falls with rates or credit stress, run-off liabilities expand, or Loews-controlled capital policy reduces minority-shareholder optionality.
Worman has emphasized selective growth, expense discipline, and capital return, including a 4% regular dividend increase to $0.48 and a $2.00 special dividend after 2025. Execution now hinges on whether underwriting and reserving regain control after Q1 2026 pressure.
Commercial insurance remains tied to economic activity, asset values, litigation trends, cyber risk, and climate volatility. Pricing cycles still matter: rate gains slowed in Q1 2026, with written rate of about +2% and retention near 83%.
CNA is not priced like a distressed insurer after its rally toward the top of the 52-week range. Margin of safety depends on normalized core EPS after reserve noise, Q2 2026 results, book-value growth ex AOCI, dividend sustainability, and whether investors accept a low-double-digit multiple for a Loews-controlled P&C franchise.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CNA price | $52.47 close on July 31, 2026 | StockAnalysis CNA overview | August 3, 2026 |
| Market capitalization | $14.19 billion, verified as $52.47 x 270.53 million shares | financial_rigor.py market cap verification | August 3, 2026 |
| Shares outstanding | 270.53 million shares | StockAnalysis share statistics | August 3, 2026 |
| Q1 2026 earnings | Net income $211 million ($0.78/share); core income $225 million ($0.83/share) | CNA Financial Q1 2026 earnings release | August 3, 2026 |
| Q1 2026 P&C underwriting | Combined ratio 102.2%; underlying combined ratio 94.5%; net written premiums $2.622 billion, up 1% | CNA Financial Q1 2026 earnings release | August 3, 2026 |
| FY2025 net income | $1.278 billion, or $4.69 per diluted share | CNA Financial FY2025 earnings release | August 3, 2026 |
| FY2025 core income | $1.342 billion, or $4.93 per diluted share (record) | CNA Financial FY2025 earnings release | August 3, 2026 |
| FY2025 P&C combined ratio | 94.7% all-in; 91.8% underlying | CNA Financial FY2025 earnings release | August 3, 2026 |
| FY2025 net investment income | $2.557 billion | CNA Financial FY2025 earnings release | August 3, 2026 |
| Book value per share | $40.13 reported; $45.12 excluding AOCI at March 31, 2026 | CNA Financial Q1 2026 earnings release | August 3, 2026 |
| Dividend | $0.48 quarterly regular dividend (about 3.66% at $52.47); trailing $3.92 including the $2.00 special dividend (about 7.47%) | StockAnalysis CNA dividend history | August 3, 2026 |
| Valuation ratios | Trailing PE 11.74x; forward PE 11.48x; price to book 1.31x on reported book value | StockAnalysis CNA statistics | August 3, 2026 |
| Controlling ownership | Loews Corporation owns approximately 92% of CNA; public float about 20.48 million shares | StockAnalysis CNA share statistics | August 3, 2026 |
| Technical snapshot | 50-day MA about $47.97; 200-day MA about $46.95; 52-week range about $41.53 to $55.71; RSI about 55.8; beta 0.30 | StockAnalysis CNA statistics | August 3, 2026 |
| Q2 2026 reporting | Q2 2026 results scheduled for August 3, 2026, before market open | CNA Financial Q2 2026 results scheduling release | August 3, 2026 |
| Sell-side view | BofA Securities raised its price target to $45 from $42 with an Underperform rating in mid-July 2026 | TheFly via StockAnalysis news | August 3, 2026 |
This CNA AI stock analysis is an informational research tool only. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available public data as of August 3, 2026 and may be wrong if CNA fundamentals, reserves, catastrophe losses, investment markets, Loews ownership policy, regulation, Q2 results, or market valuation change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
